Carrie Northcott, PhD is a director and research project lead within the Digital Medicine and Translational Imaging (DMTI) group in Early Clinical Development (ECD) at Pfizer, located in Cambridge, MA. She leads a diverse team that is evaluating and validating the use of wearable digital devices to more fully understand and characterize physiological endpoints, such as quantitatively measuring nighttime scratch and sleep. Northcott has a diverse scientific background in pharmacology, toxicology, and physiology which provides unique insight into understanding how these endpoints provide meaningful information to patients, doctors and researchers to better treat and understand diseases. Northcott received her PhD in pharmacology and toxicology from Michigan State University and her master’s and bachelor of science degrees in agricultural sciences/agronomy from the University of Illinois. She has published numerous scientific publications in various fields of scientific study and is actively involved in various scientific societies and volunteers within the community.